Design, synthesis, and structure–activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure
Molecular Diversity · 2025
DOI: 10.1007/s11030-024-10835-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von Shixiao Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Drug Design, Diketopiperazines, Tubulin Modulators. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Plinabulin, a 2, 5-diketopiperazine-type tubulin inhibitor derived from marine natural products, is currently undergoing Phase III clinical trials for the treatment of non-small cell lung cancer (NSCLC) and chemotherapy-induced neutropenia (CIN). To obtain novel 2, 5-diketopiperazine derivatives with higher biological activity, we designed and synthesized two series of 37 plinabulin derivatives at the C-ring, based on the co-crystal structure of compound 1 and tubulin. Their structures were characterized using NMR and HRMS. All compounds were screened in vitro using the lung cancer cell line NCI-H460 using the MTT method, and the compounds with better activity were further screened in BxPC-3 and HT-29 cells. The compounds 16c (IC50 = 2.0, NCI-H460; IC50 = 1.2 nM, BxPC-3; IC50 = 1.97 nM, HT-29) and 26r (IC50 = 0.96, NCI-H460; IC50 = 0.66 nM, BxPC-3; IC50 = 0.61 nM, HT-29) had the best activity. The cytotoxic activity of compound 26r against various tumor cell lines occurred at less than 1 nM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.
- Shenzhen Huahong Marine Biomedical Co., Ltd., Shenzhen, 518002, China.
- Shenzhen Huahong Marine Biomedical Co., Ltd., Shenzhen, 518002, China. dingzhongpeng@lyu.edu.cn.
- Medical College, Linyi University, Shuangling Road, Linyi, 276000, China. dingzhongpeng@lyu.edu.cn.
- School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China. tangyu@ouc.edu.cn.
- Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao, 266237, China. tangyu@ouc.edu.cn.
Förderung
- Shenzhen Science and Technology Program
Zitieren
APA
Wang, S., Zhong, C., Li, F., Ding, Z., Tang, Y., & Li, W. (2025). Design, synthesis, and structure–activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure. Molecular Diversity. https://doi.org/10.1007/s11030-024-10835-7
Vancouver
Wang S, Zhong C, Li F, Ding Z, Tang Y, Li W. Design, synthesis, and structure–activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure. Molecular Diversity. 2025. doi:10.1007/s11030-024-10835-7
BibTeX
@article{Wang2025,
author = {Wang, Shixiao and Zhong, Changjiang and Li, Feifei and Ding, Zhongpeng and Tang, Yu and Li, Wenbao},
title = {Design, synthesis, and structure–activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure},
journal = {Molecular Diversity},
year = {2025},
doi = {10.1007/s11030-024-10835-7}
}
EUVIMED